Devyser Diagnostics AB Stock: price and insider trades · Sweden

Every trade that managers of Devyser Diagnostics AB disclose to Finansinspektionen is tracked on this page. The company sits in the Health Care sector. From 18 October 2025 to 18 October 2026, the disclosure feed for Devyser Diagnostics AB logged 26 filings by 4 insiders.

Not one open-market sale was filed. On the buying side, 4 insiders reported 21 purchases totalling €493k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Mia Arnhult filed the largest purchase, €141k, on 11 November 2025, which represents 0.15% of the company's market value. The buyers include 2 board members and 2 chief executives.

In the case of 12 purchases, another manager of the company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The clock since the last published purchase (16 September 2026) now reads 31 days. The median gap between a trade and its publication by Finansinspektionen is 2 days. For comparison, MAR article 19 gives managers three business days to notify a trade.

Compared with its exchange (885 companies, median 7 filings), a count of 26 filings is above the norm. Over the whole record (from 2025), the tally stands at 23 purchases and no sales.

Other companies in the same sector with recent insider buying flagged by our signals: MAIA Biotechnology, Inc. and Cooper Companies, Inc. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.